Abstract
AbstractWe describe a case of eruptive pseudoangiomatosis triggered by the oral contraceptive Minulet® containing gestodene and ethinyloestradiol. A possible immunological mechanism in the induction of the skin lesions is suggested by the histopathological findings and a positive macrophage migration inhibition factor (MIF) test for the progesterone components in Minulet®.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the European Academy of Dermatology and Venereology
Paper Title
Journal
Date
